Skip to main content

Table 3 [18F]FDG PET parameters and TTP.  Univariate analysis of PET1, PET2 and ΔPET for TTP in the full study population (bone + soft tissue sarcoma)

From: [18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial

  HR 95% CI p value
Lower Upper
PET1-SUVmax 1.10 0.99 1.22 0.061
PET1-SUVmean 1.15 0.86 1.53 0.346
PET1-SUVpeak 1.12 0.99 1.25 0.066
PET1-MTV 1.00 0.99 1.00 0.810
PET1-TLG 1.00 0.99 1.00 0.460
PET2-SUVmax 1.30 1.12 1.51 0.001
PET2-SUVmean 1.76 1.26 1.46 0.001
PET2-SUVpeak 1.38 1.14 1.66 0.001
PET2-MTV 1.00 1.00 1.01 0.020
PET2-TLG 1.00 1.00 1.01 0.019
ΔSUVmax 1.01 0.99 1.02 0.131
ΔSUVmean 1.01 0.99 1.02 0.123
ΔSUVpeak 1.01 0.99 1.02 0.108
ΔMTV 1.01 0.99 1.02 0.146
ΔTLG 1.00 1.00 1.01 0.127